☰

Stephane Palfi - Publications

Affiliations: 
CEA, University of Paris, Fontenay-aux-Roses, Île-de-France, France 
Area:
Neurodegenerative diseases
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tremblay S, Acker L, Afraz A, Albaugh DL, Amita H, Andrei AR, Angelucci A, Aschner A, Balan PF, Basso MA, Benvenuti G, Bohlen MO, Caiola MJ, Calcedo R, Cavanaugh J, ... ... Palfi S, et al. An Open Resource for Non-human Primate Optogenetics. Neuron. PMID 33080229 DOI: 10.1016/j.neuron.2020.09.027  0.48
2019 Senova S, Clair AH, Palfi S, Yelnik J, Domenech P, Mallet L. Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: Towards an Individualized Approach. Frontiers in Psychiatry. 10: 905. PMID 31920754 DOI: 10.3389/Fpsyt.2019.00905  0.345
2019 Senova S, Mallet L, Gurruchaga JM, Rabu C, Derosin M, Yelnik J, Brugieres P, Pelissolo A, Palfi S, Domenech P. Severe Obsessive-Compulsive Disorder Secondary to Neurodegeneration With Brain Iron Accumulation: Complete Remission After Subthalamic Nuclei Deep Brain Stimulation. Biological Psychiatry. PMID 31472980 DOI: 10.1016/J.Biopsych.2019.07.006  0.305
2019 Badin RA, Binley K, Van Camp N, Jan C, Gourlay J, Robert C, Gipchtein P, Fayard A, Stewart H, Ralph GS, Lad Y, Kelleher M, Loader J, Hosomi K, Palfi S, et al. Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis. Molecular Therapy. Methods & Clinical Development. 14: 206-216. PMID 31406701 DOI: 10.1016/J.Omtm.2019.07.002  0.372
2018 Palfi S, Gurru J, Le H, Howard K, Ralph GS, Mason S, G G, Domenech P, Buttery P, Hantraye P, Tuckwell N, Barker R, Mitrophanous K. Long-term follow up of a phase 1/2 study of ProSavin, a lentiviral vector gene therapy for Parkinson's disease. Human Gene Therapy. Clinical Development. PMID 30156440 DOI: 10.1089/Humc.2018.081  0.384
2018 Senova S, Poupon C, Dauguet J, Stewart HJ, Dugué GP, Jan C, Hosomi K, Ralph GS, Barnes L, Drouot X, Pouzat C, Mangin JF, Pain F, Doignon I, Aron-Badin R, ... ... Palfi S, et al. Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Scientific Reports. 8: 3362. PMID 29463867 DOI: 10.1038/S41598-018-21486-8  0.384
2016 Stewart HJ, Ralph GS, Fong-Wong L, Strickland IT, McCloskey L, Barnes L, Blount I, Wells O, Truran CJ, Kingsman AJ, Palfi S, Mitrophanous K. Optimising transgene configuration and protein fusions to maximise dopamine production for the gene therapy of Parkinson's Disease. Human Gene Therapy. Clinical Development. PMID 27470285 DOI: 10.1089/Humc.2016.056  0.349
2016 Soulas T, Storme M, Martínez-Martín P, Pichlak M, Gurruchaga JM, Palfi S, Fénelon G. Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation study. Revue Neurologique. 172: 281-8. PMID 27158039 DOI: 10.1016/J.Neurol.2015.10.010  0.356
2016 Senova S, Hosomi K, Gurruchaga JM, Gouello G, Ouerchefani N, Beaugendre Y, Lepetit H, Lefaucheur JP, Badin RA, Dauguet J, Jan C, Hantraye P, Brugières P, Palfi S. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies. Journal of Neurosurgery. 1-9. PMID 26745490 DOI: 10.3171/2015.7.Jns15379  0.33
2016 Palfi S, Gurruchaga JM, Ralph SG, Watts C, Buttery P, Lepetit H, Miskin J, Gouello G, Lavisse S, Fenelon G, Thiriez C, Brugières P, Barker R, Hantraye P, Mitrophanous K. 367. A Dopamine Gene Therapy for Advanced PD: 4 Years Phase I/II Clinical Update Molecular Therapy. 24: S147. DOI: 10.1016/S1525-0016(16)33176-8  0.363
2015 Detorakis GI, Chaillet A, Palfi S, Senova S. Closed-loop stimulation of a delayed neural fields model of parkinsonian STN-GPe network: a theoretical and computational study. Frontiers in Neuroscience. 9: 237. PMID 26217171 DOI: 10.3389/Fnins.2015.00237  0.371
2015 Senova S, Querlioz D, Thiriez C, Jedynak P, Jarraya B, Palfi S. Using the Accelerometers Integrated in Smartphones to Evaluate Essential Tremor. Stereotactic and Functional Neurosurgery. 93: 94-101. PMID 25720954 DOI: 10.1159/000369354  0.627
2014 Thiriez C, Gurruchaga JM, Goujon C, Fénelon G, Palfi S. Spinal stimulation for movement disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 543-52. PMID 25015323 DOI: 10.1007/S13311-014-0291-0  0.301
2014 Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S, Iwamuro H, Lefaucheur JP, Thiriez C, Fenelon G, Lucas C, et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet. 383: 1138-46. PMID 24412048 DOI: 10.1016/S0140-6736(13)61939-X  0.369
2014 Haidar I, Pasillas-Lépine W, Panteley E, Chaillet A, Palfi S, Senova S. Analysis of delay-induced basal ganglia oscillations: the role of external excitatory nuclei International Journal of Control. 87: 1936-1956. DOI: 10.1080/00207179.2014.895925  0.313
2013 Thiriez C, Roubeau B, Ouerchefani N, Gurruchaga JM, Palfi S, Fénelon G. Improvement in developmental stuttering following deep brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders. 19: 383-4. PMID 22920284 DOI: 10.1016/J.Parkreldis.2012.07.011  0.386
2012 Apartis E, Blancher A, Meissner WG, Guyant-Maréchal L, Maltête D, De Broucker T, Legrand AP, Bouzenada H, Thanh HT, Sallansonnet-Froment M, Wang A, Tison F, Roué-Jagot C, Sedel F, Charles P, ... ... Palfi S, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 79: 1898-907. PMID 23077007 DOI: 10.1212/Wnl.0B013E318271F7Ff  0.335
2012 Senova S, Jarraya B, Iwamuro H, Tani N, Ouerchefani N, Lepetit H, Gurruchaga JM, Brugières P, Apartis E, de Broucker T, Palfi S. Unilateral thalamic stimulation safely improved fragile X-associated tremor ataxia: a case report. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 797-9. PMID 22287158 DOI: 10.1002/Mds.24923  0.606
2012 Fénelon G, Goujon C, Gurruchaga JM, Cesaro P, Jarraya B, Palfi S, Lefaucheur JP. Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson's disease. Parkinsonism & Related Disorders. 18: 213-4. PMID 21865071 DOI: 10.1016/J.Parkreldis.2011.07.015  0.627
2012 Hosseini H, Mandat T, Waubant E, Agid Y, Lubetzki C, Lyon-Caen O, Stankoff B, Jedynak P, Cesaro P, Palfi S, Nguyen JP. Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis. Neurosurgery. 70: 66-9. PMID 21768914 DOI: 10.1227/Neu.0B013E31822Da55C  0.317
2011 Tani N, Joly O, Iwamuro H, Uhrig L, Wiggins CJ, Poupon C, Kolster H, Vanduffel W, Le Bihan D, Palfi S, Jarraya B. Direct visualization of non-human primate subcortical nuclei with contrast-enhanced high field MRI. Neuroimage. 58: 60-8. PMID 21704174 DOI: 10.1016/J.Neuroimage.2011.06.019  0.679
2011 Soulas T, Sultan S, Gurruchaga JM, Palfi S, Fénelon G. Depression and coping as predictors of change after deep brain stimulation in Parkinson's disease. World Neurosurgery. 75: 525-32. PMID 21600507 DOI: 10.1016/J.Wneu.2010.06.015  0.339
2011 Al-ani T, Cazettes F, Palfi S, Lefaucheur JP. Automatic removal of high-amplitude stimulus artefact from neuronal signal recorded in the subthalamic nucleus. Journal of Neuroscience Methods. 198: 135-46. PMID 21463654 DOI: 10.1016/J.Jneumeth.2011.03.022  0.325
2011 Shin M, Jan C, Jacquard C, Jarraya B, Callebert J, Launay JM, Hantraye P, Remy P, Palfi S, Brouillet E. Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiology of Aging. 32: 2100-2. PMID 20018410 DOI: 10.1016/J.Neurobiolaging.2009.11.015  0.625
2010 de Andrade DC, Gurruchaga JM, Jarraya B, Goujon C, Beaugendre Y, Lepetit H, Tani N, Mandat T, Kirov K, Fenelon G, Brugières P, Palfi S. Paroxysmal positive symptoms caused by hardware malfunctioning in deep brain stimulation. Brain Stimulation. 3: 61-2. PMID 20633434 DOI: 10.1016/J.Brs.2009.07.002  0.618
2010 Jarraya B, Brugières P, Tani N, Hodel J, Grandjacques B, Fénelon G, Decq P, Palfi S. Disruption of cigarette smoking addiction after posterior cingulate damage. Journal of Neurosurgery. 113: 1219-21. PMID 20597598 DOI: 10.3171/2010.6.JNS10346  0.553
2009 Jarraya B, Boulet S, Ralph GS, Jan C, Bonvento G, Azzouz M, Miskin JE, Shin M, Delzescaux T, Drouot X, Hérard AS, Day DM, Brouillet E, Kingsman SM, Hantraye P, ... ... Palfi S, et al. Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. Science Translational Medicine. 1: 2ra4. PMID 20368163 DOI: 10.1126/Scitranslmed.3000130  0.654
2008 Palfi S, Jarraya B. Huntington's disease: genetics lends a hand. Nature. 453: 863-4. PMID 18488017 DOI: 10.1038/Nature06365  0.617
2007 Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M, Condé F, Li XJ, Aebischer P, Hantraye P, Déglon N. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1444-51. PMID 17505477 DOI: 10.1038/Sj.Mt.6300185  0.616
2004 Bloch J, Bachoud-Lévi AC, Déglon N, Lefaucheur JP, Winkel L, Palfi S, Nguyen JP, Bourdet C, Gaura V, Remy P, Brugières P, Boisse MF, Baudic S, Cesaro P, Hantraye P, et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Human Gene Therapy. 15: 968-75. PMID 15585112 DOI: 10.1089/Hum.2004.15.968  0.338
2004 Drouot X, Oshino S, Jarraya B, Besret L, Kishima H, Remy P, Dauguet J, Lefaucheur JP, Dollé F, Condé F, Bottlaender M, Peschanski M, Kéravel Y, Hantraye P, Palfi S. Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron. 44: 769-78. PMID 15572109 DOI: 10.1016/J.Neuron.2004.11.023  0.651
2004 Kishima H, Poyot T, Bloch J, Dauguet J, Condé F, Dollé F, Hinnen F, Pralong W, Palfi S, Déglon N, Aebischer P, Hantraye P. Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons. Neurobiology of Disease. 16: 428-39. PMID 15193299 DOI: 10.1016/J.Nbd.2004.03.012  0.355
2004 Gaura V, Bachoud-Lévi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S, Brugières P, Mangin JF, Boissé MF, Palfi S, Cesaro P, Samson Y, Hantraye P, Peschanski M, Remy P. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain : a Journal of Neurology. 127: 65-72. PMID 14607797 DOI: 10.1093/Brain/Awh003  0.358
2002 Roitberg BZ, Emborg ME, Sramek JG, Palfi S, Kordower JH. Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease. Neurosurgery. 50: 137-45; discussion 1. PMID 11844244 DOI: 10.1097/00006123-200201000-00022  0.34
2000 Palfi S, Leventhal L, Goetz CG, Hantraye P, Roitberg BZ, Sramek J, Emborg M, Kordower JH. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 524-530. PMID 28470737 DOI: 10.1002/1531-8257(200005)15:3<524::Aid-Mds1016>3.0.Co;2-F  0.314
2000 Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (New York, N.Y.). 290: 767-73. PMID 11052933 DOI: 10.1126/Science.290.5492.767  0.367
2000 Mittoux V, Joseph JM, Conde F, Palfi S, Dautry C, Poyot T, Bloch J, Deglon N, Ouary S, Nimchinsky EA, Brouillet E, Hof PR, Peschanski M, Aebischer P, Hantraye P. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Human Gene Therapy. 11: 1177-87. PMID 10834619 DOI: 10.1089/10430340050015220  0.367
2000 Bachoud-Lévi A, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B, Jény R, Bartolomeo P, Boissé MF, Barba GD, Degos JD, Ergis AM, Lefaucheur JP, Lisovoski F, Pailhous E, ... ... Palfi S, et al. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Experimental Neurology. 161: 194-202. PMID 10683285 DOI: 10.1006/Exnr.1999.7239  0.312
1999 Kordower JH, Bloch J, Ma SY, Chu Y, Palfi S, Roitberg BZ, Emborg M, Hantraye P, Déglon N, Aebischer P. Lentiviral gene transfer to the nonhuman primate brain. Experimental Neurology. 160: 1-16. PMID 10630186 DOI: 10.1006/Exnr.1999.7178  0.316
1999 Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, Cochran EJ, Mufson EJ, Penn R, Goetz CG, Comella CD. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Annals of Neurology. 46: 419-24. PMID 10482276 DOI: 10.1002/1531-8249(199909)46:3<419::Aid-Ana21>3.0.Co;2-Q  0.362
1998 Palfi S, Condé F, Riche D, Brouillet E, Dautry C, Mittoux V, Chibois A, Peschanski M, Hantraye P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nature Medicine. 4: 963-6. PMID 9701252 DOI: 10.1038/Nm0898-963  0.344
1998 Palfi S, Nguyen JP, Brugieres P, Le Guerinel C, Hantraye P, Remy P, Rostaing S, Defer GL, Cesaro P, Keravel Y, Peschanski M. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Experimental Neurology. 150: 272-81. PMID 9527897 DOI: 10.1006/Exnr.1997.6754  0.307
1998 Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. Journal of Neurochemistry. 70: 794-805. PMID 9453576 DOI: 10.1046/J.1471-4159.1998.70020794.X  0.323
1997 Guyot MC, Palfi S, Stutzmann JM, Mazière M, Hantraye P, Brouillet E. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats. Neuroscience. 81: 141-9. PMID 9300407 DOI: 10.1016/S0306-4522(97)00192-9  0.31
1997 Palfi S, Riche D, Brouillet E, Guyot MC, Mary V, Wahl F, Peschanski M, Stutzmann JM, Hantraye P. Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration. Experimental Neurology. 146: 135-41. PMID 9225746 DOI: 10.1006/Exnr.1997.6520  0.337
1996 Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 3019-25. PMID 8622131 DOI: 10.1523/Jneurosci.16-09-03019.1996  0.351
Show low-probability matches.